Diagnostics News and Research

RSS

TrovaGene enters definitive agreement to acquire MultiGEN

TrovaGene, Inc., a developer of trans-renal molecular diagnostics, today announced that it has entered into a definitive agreement to acquire MultiGEN Diagnostics, Inc.'s clinical laboratory assets in exchange for the issuance of 750,000 shares of common stock of TrovaGene, with an additional earn-out of up to $3.7 million in cash and common stock, subject to the achievement of specific sales and earnings targets.

6 Jan 2012

QIAGEN introduces QIAensemble Decapper to facilitate handling of liquid samples

QIAGEN N.V. announced today the launch of the QIAensemble Decapper automation system that will facilitate the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories around the world.

From QIAGEN Manchester Limited 6 Jan 2012

UCSD surgeons perform west coast's first ex-vivo liver resection

A team led by Alan Hemming, MD, transplant surgeon at UC San Diego Health System, has successfully performed the west coast's first ex-vivo liver resection, a radical procedure to completely remove and reconstruct a diseased liver and re-implant it without any tumors. The procedure saved the life of a 27-year old mother whose liver had been invaded by a painful tumor that crushed the organ and entangled its blood supply.

6 Jan 2012

Boulder Diagnostics, RUNMC enter agreement to market Lyme disease diagnostic test

Boulder Diagnostics Inc. and the Department of Internal Medicine, Radboud University Nijmegen Medical Centre announced today the entry into a license and collaboration agreement to market the innovative Lyme disease diagnostic test developed at RUNMC.

5 Jan 2012

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Itamar-Medical, the world's leader of non-invasive devices for diagnosis of cardiovascular health, announced achievement of the next milestone of the international pharmaceutical company, Roche, to further develop the EndoPAT technology for pre-clinical trials.

5 Jan 2012

Quest Diagnostics to acquire S.E.D. Medical Labs

S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.

From Quest Diagnostics 4 Jan 2012

Neogen develops new Reveal Q+ test for deoxynivalenol

Neogen Corporation has developed a new test for deoxynivalenol (DON) that combines the speed and simplicity of a lateral flow test with the fully quantitative precision of a more demanding testing method.

4 Jan 2012

TrovaGene acquires license to mutations of SF3B1 splicing factor in CLL

TrovaGene, Inc., a developer of trans-renal molecular diagnostics, today announced that it has obtained an exclusive worldwide license to mutations of the SF3B1 splicing factor, which have been shown to be associated with disease progression and chemotherapy response in patients suffering from chronic lymphocytic leukemia.

3 Jan 2012

Major European medical center includes Critical Diagnostics' Presage ST2 Assay for cardiac care

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that a major European medical center, Hospital Germans Trias i Pujol in Barcelona Spain, is now using the company's Presage ST2 Assay for routine care and management of their heart failure patients.

2 Jan 2012

Healthcare scheduling exchange solution improves preventive services for managed care organizations

It's well known that many of America's most serious health problems—and their associated cost—can be reduced or eliminated through early detection. Yet after years of effort, more than 95% of every health dollar in the United States still goes to treatment rather than prevention, according to a publication of the Centers for Disease Control. Where is the disconnect?

29 Dec 2011

FDA clears Meridian Bioscience's new Clostridium difficile assay

Meridian Bioscience, Inc., Cincinnati, Ohio today announced it has received FDA clearance for a new Clostridium difficile assay, ImmunoCard C. difficile GDH.

27 Dec 2011

Researchers warn food allergy blood tests should never be used as standalone diagnostics

An advisory from two leading allergists, Robert Wood of the Johns Hopkins Children's Center and Scott Sicherer of Mt. Sinai Hospital in New York, urges clinicians to use caution when ordering allergy tests and to avoid making a diagnosis based solely on test results.

26 Dec 2011

President Obama to provide federal funding for Alzheimer's programs

As the world's leading voluntary health organization advocating for Alzheimer's care, support and research, the Alzheimer's Association is pleased that Congress and President Obama have responded to calls by the Alzheimer's Association on behalf of people with Alzheimer's disease, caregivers, health professionals and researchers, to provide federal funding for several programs critical to the Alzheimer's community.

26 Dec 2011

UTA chemist to develop simple, paper-based test for drug-resistant TB

Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.

23 Dec 2011

JCV, CDC announce publication of 'Update on HIV Diagnostic Testing Algorithms'

Elsevier's Journal of Clinical Virology in collaboration with the US Centers for Disease Control and Prevention (CDC) today announced the publication of a special supplement entitled 'Update on HIV Diagnostic Testing Algorithms'.

23 Dec 2011

Abbott commences Esprit drug eluting BVS trial in peripheral artery disease

Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe evaluating the safety and performance of the novel Esprit drug eluting bioresorbable vascular scaffold (BVS) for the treatment of blockages in the superficial femoral arteries (SFA) and iliac arteries that have resulted in claudication.

23 Dec 2011

Siemens Medical pledges $200,000 to SIR Foundation's Discovery Campaign

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Siemens Medical Solutions, a provider of imaging and laboratory diagnostic equipment and information technology and management consulting and services to health care customers, pledged $200,000, as a "Pioneer" Supporter.

From Siemens Healthineers 21 Dec 2011

University of Illinois, Abbott establish nutrition and cognition research center

20 Dec 2011

First nutrition and cognition research center

Abbott and the University of Illinois at Urbana-Champaign announced today they have established the first-ever multi-disciplinary nutrition and cognition research center, which will be located on the Urbana campus. The Center for Nutrition, Learning, and Memory will lead directed and-solicited research on the impact of nutrition on learning and memory in the human brain.

19 Dec 2011

DDC acquires Orchid Cellmark's government paternity business

DDC (DNA Diagnostics Center), one of the largest DNA testing companies in the world, announced today the acquisition of Orchid Cellmark, Inc.'s government paternity business.

19 Dec 2011